Data / Drug companies / Biophore India Pharmaceuticals Pvt. Ltd
Biophore India Pharmaceuticals Pvt. Ltd: 41 products in the FDA NDC directory, labeler code 73435
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Biophore India Pharmaceuticals Pvt. Ltd (labeler code 73435) lists 41 products in the FDA National Drug Code Directory. By type: 41 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 16, 2026.
The request: Watch Biophore India Pharmaceuticals Pvt. Ltd (FDA labeler code 73435): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73435
- Products in commercial distribution
- 41
- Packages
- 41
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 2
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- November 5, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 41 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 41 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 39 | 95.1% |
| Crystal | 1 | 2.4% |
| Oil | 1 | 2.4% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Olaparib premix | 73435-060 | Powder | Bulk ingredients | October 16, 2026 |
| Diazoxide choline | 73435-075 | Powder | Bulk ingredients | September 15, 2026 |
| Niraparib tosylate | 73435-056 | Powder | Bulk ingredients | May 20, 2026 |
| Trofinetide | 73435-062 | Powder | Bulk ingredients | November 1, 2025 |
| Risdiplam | 73435-042 | Powder | Bulk ingredients | January 15, 2025 |
| Bempedoic acid | 73435-038 | Powder | Bulk ingredients | January 15, 2025 |
| Viloxazine hydrochloride | 73435-039 | Powder | Bulk ingredients | January 1, 2025 |
| Isavuconazonium sulfate | 73435-037 | Powder | Bulk ingredients | December 21, 2023 |
| Cenobamate | 73435-036 | Powder | Bulk ingredients | December 20, 2023 |
| Pitolisant hydrochloride | 73435-034 | Powder | Bulk ingredients | December 20, 2023 |
| Fenfluramine hydrochloride | 73435-023 | Powder | Bulk ingredients | December 20, 2023 |
| Potassium phosphate dibasic | 73435-033 | Powder | Bulk ingredients | October 31, 2023 |
| Potassium phosphate monobasic | 73435-032 | Powder | Bulk ingredients | October 31, 2023 |
| Zinc sulfate heptahydrate | 73435-025 | Powder | Bulk ingredients | December 22, 2022 |
| Tafamidis | 73435-031 | Powder | Bulk ingredients | December 21, 2022 |
| Prucalopride succinate | 73435-030 | Powder | Bulk ingredients | December 21, 2022 |
| Terazosin hydrochloride | 73435-029 | Powder | Bulk ingredients | December 21, 2022 |
| Ethiodized oil | 73435-028 | Oil | Bulk ingredients | December 21, 2022 |
| Manganese sulfate monohydrate | 73435-027 | Powder | Bulk ingredients | December 21, 2022 |
| Cupric sulfate pentahydrate | 73435-026 | Crystal | Bulk ingredients | December 21, 2022 |
| Tafamidis meglumine | 73435-024 | Powder | Bulk ingredients | December 21, 2022 |
| Tegaserod | 73435-022 | Powder | Bulk ingredients | December 21, 2022 |
| Elagolix sodium | 73435-021 | Powder | Bulk ingredients | December 8, 2021 |
| Calteridol calcium | 73435-016 | Powder | Bulk ingredients | December 8, 2021 |
| Molnupiravir | 73435-018 | Powder | Bulk ingredients | December 6, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.